Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Diagen AS
AS
Active
Org 987520590
Mosseveien 60, 1640
Råde
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2004 · 21 years old
8 employees
www.diagen.no
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Diagen AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
98M
74M
49M
25M
0M
2021: 79M
79M
2021
2022: 18M (-77% vs 2021)
18M
-77%
2022
2023: 8M (-56% vs 2022)
8M
-56%
2023
2024: 14M (+75% vs 2023)
14M
+75%
2024
2025: 17M (+21% vs 2024)
17M
+21%
2025
EBITDA
NOK millions
50M
32M
14M
-3M
-21M
2021: 36M
36M
2021
2022: -2M (-106% vs 2021)
-2M
-106%
2022
2023: -7M (-250% vs 2022)
-7M
-250%
2023
2024: -3M (+57% vs 2023)
-3M
+57%
2024
2025: 0M (+100% vs 2024)
0M
+100%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
17 003
13 508
8 288
18 235
78 581
Staff expenses
−6 827
−7 099
−7 846
−8 380
−6 881
EBITDA
−180
−3 102
−7 338
−2 293
35 878
Depreciation & amort.
−605
−489
−564
−3 498
−1 230
EBIT
−786
−3 591
−7 902
−5 791
34 648
Net financials
−154
−4 366
22 539
−655
55 410
Profit before tax
−940
−7 957
14 636
−6 446
90 058
Tax
−0
−0
−0
−210
6 159
Net profit
−940
−7 957
14 636
−6 236
83 899
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
38 145
26 185
45 827
83 265
245 013
Equity
6 455
7 220
14 565
1 574
7 810
Long-term debt
23 808
9 209
22 713
77 363
210
Short-term debt
7 883
9 756
8 549
4 328
236 993
Total debt
31 690
18 965
31 262
81 691
237 203
Financial ratios
5-year trend
EBITDA margin
−1,1 %
This company
15,8 %
Market median
This company
Market median
107% below market
2021
2025
Equity ratio
16,9 %
This company
38,2 %
Market median
This company
Market median
56% below market
2021
2025
Return on equity
−14,6 %
This company
18,4 %
Market median
This company
Market median
179% below market
2021
2025
Net profit margin
−5,5 %
This company
8,1 %
Market median
This company
Market median
168% below market
2021
2025
Asset turnover
0,45×
This company
1,12×
Market median
This company
Market median
60% below market
2021
2025
Debt / equity
4,91×
This company
0,62×
Market median
This company
Market median
692% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Diagen AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
